Autologous bone marrow-derived endothelial progenitor cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous bone marrow-derived endothelial progenitor cells, covering 2015-05-27 to 2015-05-27. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate Safety and Efficacy of Autologous Bone Marrow-derived Endothelial Progenitor Cells in Advanced Liver Cirrhosis [Phase 1, Phase 2]